what's possible
See what’s next in managing your patients’ vision care needs with advanced VTI contact lens technology.
For those who’ve experienced it, you know NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day Contact Lenses redefine vision for presbyopes and help you take control of paediatric myopia. With Neurofocus Optics® technology, these lenses offer crisp, clear vision at all distances1 and demonstrate a 96% decrease in the rate of myopia progression.2
Studies show that NaturalVue® (etafilcon A) Enhanced Multlfocal 1 Day contact lenses can reduce myopia progression. NaturalVue help children flourish by not only providing excellent vision for everyday tasks, but also helps control one of the risk factors for excessive ocular growth that contributes to myopic progression.
Featuring Patented Neurofocus Optics® Technology with an extended depth of focus (EDOF), centre distance design.1
NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day Contact Lenses create an extended depth of focus to deliver a wider range of clear vision—unlike single vision or traditional multifocal lenses.1
Getting started with NaturalVue® Enhanced Multifocal 1 Day Contact Lenses has never been easier.
Las Vegas, Nevada, January 8, 202
Myopia progression minimization continued over 2 Years with the NaturalVue®
Multifocal 1 Day Contact Lens.
VTI will be introducing new brand packaging for NaturalVue® Enhanced Multifocal 1 Day Contact Lenses.
New Data for Myopic Astigmatic Patients (GSLS)
Positive Interim 2-Year PROTECT (GSLS)
Celebrating Excellence in the UK Optical Industry
VTI Releases Defocus Curve Data Evaluating the Functional Visual Range of the NaturalVue® Enhanced Multifocal EDOF Design for Presbyopia
VTI Continues Release of 1-Year Data from the Ongoing PROTECT Clinical Trial for Myopia Progression Control at the Global Specialty Lens Symposium
VTI Announces Positive Interim 1-Year Data from the PROTECT Clinical Trial for Myopia Progression Control at the American Academy of Optometry Annual Meeting
Dr. Juan Carlos Aragón named as VTI’s Chief Executive Officer and Executive Director
VTI Launches the MyPath Myopia Education Initiative: The Path to Success in the Management of Myopia
6-Year Myopia Progression Data for NaturalVue® Multifocal Announced at American Academy of Optometry’s Annual Meeting
Visioneering Technologies, Inc. Appoints Ashley Tuan, OD, PhD as Chief Medical Officer
The Enhanced Multifocal 1 Day™ Contact Lenses feature the TripleTear™ Lubrication System and a new Ultra-Tapered Edge
VTI has Confirmed with its Manufacturer that no NaturalVue Soft Contact Lenses are Formulated with Fluorinated Polymers or PFAS
Visioneering Technologies Launches New NaturalVue® Enhanced Multifocal™ in 7 Markets Simultaneously
Visioneering Technologies Announces Publication of Peer-Reviewed Data from a 6-Year Myopia Progression Study in Clinical Ophthalmology
Visioneering Achieves 50% Enrollment Milestone in its PROTECT International Clinical Study for Myopia Progression Control
As video game use increases, the Global Myopia Awareness Coalition brings its message to gamers.
VTI enters European sales and distribution agreement with Menicon, Japan’s largest contact lens company.
The first installment discusses treatment of children in clinical practice and features insights from world leading researchers and clinicians.
Clinical study shows new CleanComfort® technology provides more comfortable lens wear morning and night.
Company now provides most expansive parameter range of any daily disposable multifocal.1
Visioneering wins Award of Excellence for its NaturalVue® Multifocal 1 Day Contact Lenses at Australia’s largest eyecare event.
Visioneering Technologies, Inc., Sponsors “The Truth about Myopia – Part 2.”
Visioneering continues Asia expansion with registration achieved in Singapore.
VTI Vision Global is proudly powered by WordPress